AZD-1940 is a drug formulated by AstraZeneca, that is a peripherally selective cannabinoid agonist which binds with superior affinity to the two the CB1 and CB2 receptors. It had been formulated to the cure of neuropathic soreness, but though it showed excellent peripheral selectivity in animal scientific studies,[one] in human medical trials it di